Michael Mithoefer, MD is a Clinical Investigator and acting Medical Director of MAPS Public Benefit Corporation. Together with his wife Annie, they completed the first phase 2 clinical trial of MDMA-assisted psychotherapy for PTSD in 2009 and a subsequent study of MDMA-assisted psychotherapy for PTSD in military veterans, firefighters and police officers. They are now supervising therapists in the ongoing MAPS Phase 3 trials of MDMA-assisted Psychotheapy for PTSD, leading training in MDMA- assisted psychotherapy for therapists interested in working on clinical trials, and providing FDA-approved MDMA sessions for research therapists.
Michael is Clinical Assistant Professor of Psychiatry at the Medical University of South Carolina, is a Grof certified Holotropic Breathwork Practitioner, has been a Certified Internal Family Systems Therapist, and has been board certified in Psychiatry, Emergency Medicine and Internal Medicine.
Annie is a registered nurse as well as a Grof-certified Holotropic Breathwork Practitioner, is trained in Hakomi Therapy, and has 25 years experience working with trauma patients, with an emphasis on experiential approaches to therapy.
Tune in to this episode to find out about their pioneer work with MDMA and their most recent research!
MDMA-assisted psychotherapy
MDMA
Psychedelics
Stanislav Grof
Breathwork
EMDR
Neurofeedback
Francine Shapiro
FDA
Rick Doblin
MAPS
IRB
DEA
CAPS-5 - Clinician Administered PTSD Scale
Exposure therapy
Cognitive-behavioral conjoint therapy
Candice Monson
Amygdala
Relax beliefs under psychedelics (REBUS)
PTSD
EMA - European Medicines Agency
Psilocybin
Ayahuasca
★ Support this podcast ★